S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
NYSE:BIO

Bio-Rad Laboratories Earnings Date, Estimates, & History

$721.48
+1.37 (+0.19 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$713.22
$725.47
50-Day Range
$708.84
$825.77
52-Week Range
$507.22
$832.70
Volume100,900 shs
Average Volume156,088 shs
Market Capitalization$21.48 billion
P/E Ratio5.38
Dividend YieldN/A
Beta0.85

Earnings Summary

Upcoming
Earnings Date
Oct. 28
Confirmed

Actual EPS
(Jul. 28)
$3.54
Beat By $0.88

Consensus EPS
(Jul. 28)
$2.66

Last Year's Q3 EPS
(7/30/2020)
$1.61

Skip Charts & View Estimated and Actual Earnings Data

Bio-Rad Laboratories Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Bio-Rad Laboratories Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bio-Rad Laboratories (NYSE:BIO) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211$2.50$2.50$2.50 
Q2 20211$2.56$2.56$2.56 
Q3 20211$2.18$2.18$2.18 
Q4 20211$2.51$2.51$2.51 
FY 20214$9.75$9.75$9.75
Q1 20221$2.85$2.85$2.85 
Q2 20221$3.05$3.05$3.05 
Q3 20221$2.94$2.94$2.94 
Q4 20221$3.16$3.16$3.16 
FY 20224$12.00$12.00$12.00

BIO Earnings Information

Bio-Rad Laboratories last announced its quarterly earnings data on July 28th, 2021. The medical research company reported $3.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.66 by $0.88. The company earned $715.93 million during the quarter, compared to analyst estimates of $610.40 million. Bio-Rad Laboratories has generated $10.52 earnings per share over the last year ($134.15 diluted earnings per share) and currently has a price-to-earnings ratio of 5.4. Earnings for Bio-Rad Laboratories are expected to decrease by -13.03% in the coming year, from $14.20 to $12.35 per share. Bio-Rad Laboratories has confirmed that its next quarterly earnings report will be published on Thursday, October 28th, 2021.

Bio-Rad Laboratories (NYSE:BIO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
10/28/2021
(Confirmed)
 $2.30      
7/28/20216/30/2021$2.66$3.54+$0.88($23.24)$610.40 million$715.93 million    
4/29/20213/31/2021$2.50$5.21+$2.71($21.96)$661.00 million$726.80 million  
2/10/202112/31/2020$3.30$4.01+$0.71($19.79)$681.80 million$789.84 million  
10/29/20209/30/2020$1.85$3.00+$1.15($37.64)$567.35 million$647.26 million    
7/30/2020Q2 2020$1.22$1.61+$0.39($28.93)$526.80 million$536.88 million  
5/6/20203/31/2020$1.57$1.91+$0.34($18.90)$545.70 million$571.60 million    
2/13/2020Q4 2019$2.44$2.32($0.12)($13.67)$636.50 million$624.43 million  
10/31/2019Q3$1.36$1.61+$0.25$11.90$561.40 million$560.60 million  
8/1/2019Q2 2019$1.39$1.57+$0.18($16.72)$564.88 million$572.60 million    
5/8/20193/31/2019$1.12$1.65+$0.53($25.44)$548.82 million$553.98 million    
2/28/2019Q4 2018$1.61$2.13+$0.52$32.14$610.65 million$617.54 million
11/1/20189/30/2018$1.16$0.91($0.25)($7.07)$541.23 million$545.10 million  
8/7/2018Q2 2018$1.27$1.64+$0.37($5.59)$551.05 million$575.91 million
5/8/2018Q1 2018$1.07$1.17+$0.10($19.43)$527.20 million$551.52 million
2/27/2018Q4 2017$1.28$1.50+$0.22$0.68$618.89 million$620.43 million
11/2/2017Q3 2017$0.54$0.91+$0.37$0.91$507.99 million$535.00 million
8/3/2017Q2 2017$0.63$0.58($0.05)$0.99$515.04 million$504.67 million
5/4/2017Q1 2017$0.27$0.41+$0.14$0.41$477.76 million$500.05 million  
2/23/2017Q416$1.03($0.70)($1.73)$3.20$574.40 million$571.45 million
11/1/2016Q316$0.51$0.62+$0.11$0.62$480.60 million$508.75 million
8/3/2016Q2$1.13$0.61($0.52)$0.61$497.80 million$516.80 million
5/5/2016Q1$0.60$0.42($0.18)$0.42$463.90 million$471.20 million
2/25/2016Q415$1.27$1.68+$0.41$1.68$570.80 million$570.56 million  
11/3/2015Q315$0.54$0.59+$0.05$0.59$495.55 million$469.96 million
8/6/2015Q215$0.78$0.97+$0.19$0.97$494.85 million$506.10 million
5/5/2015Q115$0.33$0.61+$0.28$0.61$474.60 million$472.80 million
2/26/2015Q414$1.18$1.34+$0.16$1.34$593.41 million$598.20 million
11/4/2014Q314$0.86$0.39($0.47)$0.39$525.40 million$530.64 million
8/5/2014Q214$0.95$1.09+$0.14$1.09$537.58 million$536.80 million  
5/6/2014Q114$0.80$0.23($0.57)$0.23$515.00 million$509.30 million
2/27/2014Q413$1.42$1.04($0.38)$586.67 million$602.60 million  
11/8/2013Q3 2013$0.66$0.56($0.10)$1.37$529.02 million$505.10 million  
8/6/2013Q2 2013$1.12$1.20+$0.08$1.20$532.60 million$525.30 million  
5/7/2013Q1 2013$1.10$0.68($0.42)$0.68$506.34 million$499.70 million
2/26/2013Q4 2012$1.33$1.65+$0.32$558.68 million$573.80 million  
11/6/2012Q312$1.14$1.48+$0.34$507.79 million$498.70 million
8/7/2012$1.19$1.69+$0.50
5/1/2012$1.02$1.09+$0.07  
2/23/2012$1.67$2.08+$0.41
11/1/2011$1.53$1.61+$0.08
8/2/2011$1.47$1.41($0.06)
5/3/2011$1.32$1.16($0.16)
2/24/2011$1.35$2.41+$1.06
11/2/2010Q3 2010$1.17$1.59+$0.42$1.59
8/3/2010Q2 2010$1.27$1.35+$0.08$1.35
5/4/2010Q1 2010$1.17$1.24+$0.07$1.24
2/24/2010Q4 2009$1.08$1.49+$0.41$1.63
11/3/2009Q3 2009$1.00$1.38+$0.38$1.38
8/4/2009Q2 2009$1.03$1.37+$0.34$1.37
5/5/2009Q1 2009$0.98$1.10+$0.12$1.10
2/26/2009Q4 2008$0.90$1.18+$0.28$2.66
11/6/2008Q3 2008$1.06$1.01($0.05)$1.01
8/5/2008Q2 2008$1.08$1.58+$0.50$1.58
5/6/2008Q1 2008$0.99$0.97($0.02)$0.97
2/28/2008Q4 2007$0.80$0.92+$0.12$1.39
(Earnings results data provided by Zacks Investment Research)












Bio-Rad Laboratories (NYSE:BIO) Earnings Frequently Asked Questions

When is Bio-Rad Laboratories's earnings date?

Bio-Rad Laboratories has confirmed that its next quarterly earnings data will be published on Thursday, October 28th, 2021. Learn more on BIO's earnings history

Did Bio-Rad Laboratories beat their earnings estimates last quarter?

In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $3.54 earnings per share (EPS) to beat the analysts' consensus estimate of $2.66 by $0.88. Learn more on BIO's earnings details

How can I listen to Bio-Rad Laboratories's earnings conference call?

The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call

How can I read Bio-Rad Laboratories's conference call transcript?

The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript

How much revenue does Bio-Rad Laboratories generate each year?

Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.55 billion.

How much profit does Bio-Rad Laboratories generate each year?

Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of $3.81 billion. BIO has generated $10.52 earnings per share over the last four quarters.

What is Bio-Rad Laboratories's price-to-earnings ratio?

Bio-Rad Laboratories (NYSE:BIO) has a trailing price-to-earnings ratio of 5.38 and a forward price-to-earnings ratio of 50.81.

What is Bio-Rad Laboratories's EPS forecast for next year?

Bio-Rad Laboratories's earnings are expected to decrease from $14.20 per share to $12.35 per share in the next year, which is a -13.03% change.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.